Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking for Charity - 2007 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (171)	1/6/2007 1:14:31 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 397

Steve..not a direct tie to the question that you asked Jim, but the attached article points out and gives those who oppose stem cell research another issue to bring into the mix. I wish issues like this wouldn't be brought into the fray, as we need unencumbered true medical research into whether or not stem cells can address certain medical needs. Sadly...this is happening in Texas.... msnbc.msn.com

To: Steve Lokness who wrote (171)	1/8/2007 8:10:50 PM
From: Biotech Jim	Read Replies (1) \| Respond to of 397

Steve- Concerning your stem cell question, my take is that we are in inning 2 or 3 in a nine inning game in which a lot of runs are to be scored in both the early and the later innings. There is no doubt that cell and organ replacement via stem cells is a desirable approach towards longevity and self preservation. I do not follow this research space closely, so I do not have opinions on the companies involved. My thoughts are that this is a tough area. IP on cells, as well as know how on how to stop cell growth, are and will continue to be very important. BJ